Carlo Tanzi | IR |
Eric Shaff | President and CEO |
Lisa von Moltke | Chief Medical Officer |
Matthew Henn | Chief Scientific Officer |
Terri Young | Chief Commercial and Strategy Officer |
David Ege | Chief Technology Officer |
Ted Tenthoff | Piper Sandler |
Joseph Thome | Cowen & Company |
Mark Breidenbach | Oppenheimer |
Terence Flynn | Goldman Sachs |
Chris Howerton | Jefferies |
John Newman | Canaccord Genuity |
Ladies and gentlemen, thank you for standing by, and welcome to the Q4 2020 Seres Therapeutics' Earnings Conference Call. At this time all participants are in a listen mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Dr.